Fusen Pharmaceutical Company Limited (HKG:1652)
1.260
+0.010 (0.80%)
Apr 2, 2026, 3:58 PM HKT
HKG:1652 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 83.84 | 21.06 | 34.85 | 128.11 | 81.06 |
Short-Term Investments | - | - | - | - | 0.64 |
Cash & Short-Term Investments | 83.84 | 21.06 | 34.85 | 128.11 | 81.71 |
Cash Growth | 298.19% | -39.58% | -72.80% | 56.79% | -73.86% |
Accounts Receivable | 121.96 | 113.88 | 183.48 | 247.19 | 157.58 |
Other Receivables | - | 145.39 | 114.15 | 66.85 | 103.61 |
Receivables | 121.96 | 259.27 | 297.63 | 314.04 | 261.19 |
Inventory | 98.06 | 153.35 | 184.2 | 123.49 | 128.97 |
Prepaid Expenses | - | 8.56 | 5.49 | - | - |
Other Current Assets | 190.84 | 17.39 | 44.63 | 48.43 | 37.35 |
Total Current Assets | 494.69 | 459.61 | 566.8 | 614.06 | 509.22 |
Property, Plant & Equipment | 550.37 | 621.33 | 562.18 | 529.75 | 506.03 |
Long-Term Investments | 58.92 | 43.88 | 148.97 | 178.31 | 198.06 |
Other Intangible Assets | 28.03 | 28.14 | 22.55 | 0.48 | 0.68 |
Long-Term Deferred Tax Assets | 2.48 | 6.64 | 5.02 | 5.08 | 5.63 |
Other Long-Term Assets | 128.94 | 78.57 | 38.22 | 22.6 | 19.7 |
Total Assets | 1,263 | 1,238 | 1,344 | 1,350 | 1,239 |
Accounts Payable | 148.16 | 123.47 | 167.55 | 163.61 | 102.12 |
Accrued Expenses | 426.95 | 160.84 | 147.32 | 157.57 | 143.76 |
Short-Term Debt | 293.28 | 4.61 | 4.61 | 230.45 | 150.52 |
Current Portion of Long-Term Debt | - | 303.54 | 236.56 | - | 20 |
Current Portion of Leases | 0.46 | 0.92 | 1.09 | 2.11 | 1.83 |
Current Income Taxes Payable | 5.12 | 5.51 | 6.09 | 7.15 | - |
Current Unearned Revenue | 2.68 | 8.94 | 3.9 | 67.55 | 4.62 |
Other Current Liabilities | - | 164.63 | 97.43 | 93.65 | 66.42 |
Total Current Liabilities | 876.65 | 772.45 | 664.52 | 722.08 | 489.27 |
Long-Term Debt | 7 | 79.1 | 105.7 | - | 76 |
Long-Term Leases | 0.49 | 0.13 | 0.77 | 0.43 | 1.94 |
Long-Term Unearned Revenue | 21.37 | 18.12 | 10.23 | 11.32 | 10.51 |
Long-Term Deferred Tax Liabilities | - | - | 0.3 | 3.54 | 4.68 |
Total Liabilities | 905.51 | 869.8 | 781.52 | 737.38 | 582.39 |
Common Stock | 6.18 | 6.18 | 6.31 | 6.38 | 6.48 |
Additional Paid-In Capital | - | 224.23 | 230.78 | 246.73 | 259.46 |
Retained Earnings | - | 103.82 | 292.61 | 328.88 | 363.49 |
Treasury Stock | - | - | -0.08 | -0.05 | -0.04 |
Comprehensive Income & Other | 353.07 | 35.44 | 33.91 | 32.22 | 28.79 |
Total Common Equity | 359.25 | 369.67 | 563.52 | 614.17 | 658.17 |
Minority Interest | -1.33 | -1.31 | -1.29 | -1.27 | -1.23 |
Shareholders' Equity | 357.92 | 368.36 | 562.23 | 612.89 | 656.94 |
Total Liabilities & Equity | 1,263 | 1,238 | 1,344 | 1,350 | 1,239 |
Total Debt | 301.23 | 388.3 | 348.72 | 232.99 | 250.29 |
Net Cash (Debt) | -217.39 | -367.24 | -313.87 | -104.88 | -168.59 |
Net Cash Per Share | -0.29 | -0.50 | -0.42 | -0.14 | -0.22 |
Filing Date Shares Outstanding | 742.96 | 739.3 | 745.04 | 758.21 | 764.82 |
Total Common Shares Outstanding | 742.96 | 739.3 | 745.04 | 758.21 | 764.82 |
Working Capital | -381.95 | -312.83 | -97.72 | -108.03 | 19.96 |
Book Value Per Share | 0.48 | 0.50 | 0.76 | 0.81 | 0.86 |
Tangible Book Value | 331.22 | 341.54 | 540.97 | 613.68 | 657.49 |
Tangible Book Value Per Share | 0.45 | 0.46 | 0.73 | 0.81 | 0.86 |
Buildings | - | 294.82 | 278.2 | 278.02 | 220.23 |
Machinery | - | 234.79 | 204.33 | 144.85 | 142.73 |
Construction In Progress | - | 21.93 | 3.46 | 0.58 | 4.79 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.